Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03478761 · ClinicalTrials.gov registry record
24-Hydroxylase Deficiency and CYP24A1 Mutation Patient Registry
A clinical trial of 24-hydroxylase Deficiency, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT03478761: Recruiting study of 24-hydroxylase Deficiency, sponsored by Mayo Clinic.
NCT03478761 is a study of 24-hydroxylase Deficiency that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 600 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03478761, a study of 24-hydroxylase Deficiency, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
You are being asked to take part in this research registry because you or your family member is suspected to have a 24-hydroxylase deficiency.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2017-10-19 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03478761
The ClinicalTrials.gov registry entry for NCT03478761 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with 24-hydroxylase Deficiency appearing as the primary indexed condition, and to 0 interventions.
NCT03478761 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03478761 about?
NCT03478761 is a clinical study titled "24-Hydroxylase Deficiency and CYP24A1 Mutation Patient Registry". You are being asked to take part in this research registry because you or your family member is suspected to have a 24-hydroxylase deficiency.
What is the current status of trial NCT03478761?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2017-10-19. Estimated completion is 2030-12.
What conditions does trial NCT03478761 study?
This clinical trial studies the following conditions: 24-hydroxylase Deficiency.
Who is sponsoring clinical trial NCT03478761?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03478761 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.